Current status and perspectives in stem cell therapy for heart

Fen Chiung Lin, Wen Pin Chen, Pao Hsien Chu, Kou Gi Shyu, Ming Shien Wen

研究成果: 雜誌貢獻回顧型文獻同行評審


Formost patients, the prognosis of heart failure remains poor despite therapeutic advancement in recent decades. The option of cardiac transplantation is high risk and limited by a shortage of donors. Traditionally, the heart had been considered a terminally differentiated organ incapable of regeneration. However, numerous preclinical and clinical studies have been performed since the first report of cell therapy in heart failure using skeletalmyoblasts in 2001. These investigations looked at the promising potential and use of several kinds of stem cells, which could some day dramatically alter the understanding of the regenerative capacity of the heart. To date, although there is no existing cardiac cell therapy that has been conclusively reported to be effective, stem cell-related cardiomyocyte regeneration strategies have become significant areas of research in modern cardiovascular medicine. In this review,we outline a variety of common cell sources, surface biomarkers of stem cells, and provide information related to cardiac cell therapy clinical trials.
頁(從 - 到)382-394
期刊Acta Cardiologica Sinica
出版狀態已發佈 - 9月 1 2014

ASJC Scopus subject areas

  • 心臟病學與心血管醫學


深入研究「Current status and perspectives in stem cell therapy for heart」主題。共同形成了獨特的指紋。